Effectiveness of electroacupuncture and laseracupuncture in the health of post-covid-19 patients: randomized clinical trial - COVID-19 COVID-19

niversidade Estadual de Maringá0 个研究点开始时间: 2022年3月31日最近更新: 2023年5月29日

试验速览

暂无简介。

•Age between 18 and 59 years; history of positive testing for SARS-Cov-2; with new or persistent symptoms since the acute phase of the disease lasting at least two months, unexplained by an alternative diagnosis; that has one or more of the following characteristics: altered spirometry parameters; fatigue score greater than 4; anxiety score equal to or greater than 11; score on the depression scale equal to or greater than 8; not having a contraindication factor for performing electroacupuncture and laseracupuncture; not being on specific clinical treatment for the post-COVID-19 syndrome; present agreement with the Free and Informed Consent Form signed in two copies; agree to participate in the proposed tests.

•Institutionalized people; who do not present the signature of the Free and Informed Consent Form; who do not fit into the aforementioned age group; history of carcinoma; neoplasms; physical disability; motor and/or cognitive; use of metallic prostheses; pacemaker; photosensitivity history; contraindication for the use of photobiomodulation (melanin changes; history of burns); current treatment/follow-up other than usual care. Pregnant women, people with severe mental disorders, risk of suicide attempt, people with hormonal disorders, people who are under any therapeutic intervention of traditional Chinese medicine will also not be included.

发起方

niversidade Estadual de Maringá